Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Lichtenfeld

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Oncology|January 1, 1975
Combined modality therapy for localized Hodgkin's disease. A seven-year update of an early studyP H Wiernik, J L Lichtenfeld
Diagnostic Imaging|January 1, 1981
Lymph node calcification secondary to chemotherapy for histiocytic lymphomaM E Bohlman, J L Lichtenfeld, S M Goldman
The American Journal of Medicine|February 1, 1976
Familial Sjögren's syndrome with associated primary salivary gland lymphomaJ L Lichtenfeld, R H Kirschner, P H Wiernik
Cancer Treatment Reports|May 1, 1976
Modulating effects of levamisole (NSC-177023) on human lymphocyte response in vitroJ L Lichtenfeld, M R Desner, P H Wiernik, et al.
Cancer Research|October 1, 1976
Abnormalities of complement and its components in patients with acute leukemia, Hodgkin's disease, and sarcomaJ L Lichtenfeld, P H Wiernik, M R Mardiney, et al.
Cancer|May 11, 1976
Antibody response in patients with acute nonlymphocytic leukemiaC A Schiffer, J L Lichtenfeld, P H Wiernik, et al.
Journal of the National Cancer Institute|January 11, 1975
A new apparatus for BCG scarificationM R Desner, J L Lichtenfeld, C L Dennison, et al.
Cancer Treatment Reports|January 1, 1980
Phase I trial of pentamethylmelamine in patients with previously treated malignanciesD A Van Echo, D F Chiuten, M Whitacre, et al.
Journal of the National Cancer Institute|November 11, 1975
Abnormal profile of human nucleolytic activity as a test for cancerW P Drake, M Schmukler, W J Pendergrast, et al.
Cancer Research|October 1, 1979
Phase I clinical and pharmacological study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide using an intermittent biweekly scheduleD A Van Echo, D F Chiuten, P E Gormley, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Oncology|January 1, 1975
Combined modality therapy for localized Hodgkin's disease. A seven-year update of an early studyP H Wiernik, J L Lichtenfeld
Diagnostic Imaging|January 1, 1981
Lymph node calcification secondary to chemotherapy for histiocytic lymphomaM E Bohlman, J L Lichtenfeld, S M Goldman
The American Journal of Medicine|February 1, 1976
Familial Sjögren's syndrome with associated primary salivary gland lymphomaJ L Lichtenfeld, R H Kirschner, P H Wiernik
Cancer Treatment Reports|May 1, 1976
Modulating effects of levamisole (NSC-177023) on human lymphocyte response in vitroJ L Lichtenfeld, M R Desner, P H Wiernik, et al.
Cancer Research|October 1, 1976
Abnormalities of complement and its components in patients with acute leukemia, Hodgkin's disease, and sarcomaJ L Lichtenfeld, P H Wiernik, M R Mardiney, et al.
Cancer|May 11, 1976
Antibody response in patients with acute nonlymphocytic leukemiaC A Schiffer, J L Lichtenfeld, P H Wiernik, et al.
Journal of the National Cancer Institute|January 11, 1975
A new apparatus for BCG scarificationM R Desner, J L Lichtenfeld, C L Dennison, et al.
Cancer Treatment Reports|January 1, 1980
Phase I trial of pentamethylmelamine in patients with previously treated malignanciesD A Van Echo, D F Chiuten, M Whitacre, et al.
Journal of the National Cancer Institute|November 11, 1975
Abnormal profile of human nucleolytic activity as a test for cancerW P Drake, M Schmukler, W J Pendergrast, et al.
Cancer Research|October 1, 1979
Phase I clinical and pharmacological study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide using an intermittent biweekly scheduleD A Van Echo, D F Chiuten, P E Gormley, et al.
Pageof 2